Microsoft Azure, Parexel to launch a real-world data platform for COVID-19

Microsoft Azure, Parexel to launch a real-world data platform for COVID-19

Microsoft Azure, Parexel to launch a real-world data platform for COVID-19

Parexel, a contract research organization, has recently launched a new research platform powered by Microsoft Azure. This was launched to allow quick access to all the COVID-19 related data with the help of Parexel’s expertise in real-world evidence combined with the cloud tech of Microsoft. This is an effort to provide support to healthcare professionals, doctors, and researchers to better understand and adjust the treatment while facing the pandemic in real-time. The pair has been in a cloud tech alliance since 2017 and will be using those years of experience to operate the #KeepingPatientsFirst platform. It works by aggregating, analyzing, and forecasting the real-world coronavirus disease progression and its potential outcomes with the use of machine learning, artificial intelligence, and data analytics.

This can help the virus affected patients to get the right treatments at the right time. This is an epidemiological approach that will help to define and characterize an unprecedented global crisis and will also document the patient’s journey from awareness to diagnosis to disease resolution, speeding up the evaluation process of the potential COVID-19 therapies. Deploying traditional processes of executing randomized controlled phases of clinical trials that require in-person subject availability over a spread of months or maybe years is just not feasible in the current scenario. The #KeepingPatientsFirst platform uses highly advanced technology capabilities combined with industry-leading expertise to explore and analyze the processing of information to work with the researchers and regulators in order to save lives.

Parexel has also declared a temporary halt on its new patient screenings and enrolment, which is only specific to its four global early phase clinical units. These units are still open and are conducting ongoing studies, but new enrolments are on hold in order to ensure that Parexel is practicing safe social distancing, and patient safety is its primary goal. Meanwhile, tech giant Microsoft teamed up with UnitedHealth Group earlier this month to launch a free Smartphone app in the market which businesses and employees can use to digitally screen the symptoms of the novel coronavirus and clear those who can safely return to work.